Taflotan Ophthalmic Solution 0.0015%
Prescription Only
Drug type: Therapeutic
ATC code: S01EE05
Dosage form: SOLUTION, STERILE
Route of administration: OPHTHALMIC
Active ingredient: Tafluprost
Indications
Reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.
Contraindications (This product is contraindicated in the following patients.)
Patients with a history of hypersensitivity to any of the ingredients of this product. Patients with combination with products containing omidenepag isopropyl.
Dosage and Administration
Instill 1 drop in the affected eye(s) once daily.
Do not use more than once daily because more frequent administration may lessen the IOP-lowering effect.
Registrant
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Approval Date
2010-10-07
Approval Number
SIN13872P
Manufacturer
Santen Pharmaceutical Co., Ltd. Shiga Plant
Licence Holder
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Package Insert
PI_Taflotan_Singapore.pdf
View